Tuesday, 23 Jan 2018

You are here

8 September 2017: The RheumNow Week in Review

The RheumNow Week in Review discusses the past week's news, journal articles and highlights from RheumNow.com. This week's report includes trends in MTX use and outcomes, fibromyalgia as an inflammatory disorder, drugs that stop psoriasis pruritus, drugs that don't cause TB, cardiovascular risk and what Rheums think of ACR/EULAR criteria.

  1. 192 Chronic fatigue patient show high TGF-B,low resistin, 17 cytokines correlate with activity(CXCL*, GF, IL-4, IL5, IL7, IL13, IL17F, several growth factors. https://buff.ly/2xa8A8k 
  2. Between 2004-2014, MTX use increased (40% to 64%) and biologic use increased (from to1.7% to 27%), but the rate of ortho hip and knee surgery dropped (72 to 51/1000pts in 2014) https://t.co/IE72n2YMPB
  3. Optimal MTX dosing in early #RA patients (≥10mg/wk w/in 3 mos and ≥20mg/wk @6mo) improves clinical & functional but not Xray outcomes https://t.co/dJQjFrub4Q
  4. A review of 230 SLE patients, 95 had both abnormal protein-creatinine ratio (PCR) AND a 24 Hr Protein measures; serial assessments showed PCR had insufficient accuracy vs 24hr-Prot measures https://t.co/UjtoRagWAF
  5. Base on claims data, prevalence of RA increased over 10 yr period; RA found in 1.28-1.36 million adults (or roughly 0.5%) by 2014 https://t.co/t5GwPsifIC
  6. Psoriasis pruritus seen in >80%; metaanalysis 13 trials shows Anti Il-17, JAK inhib, ADA, apremilast reduce pruritus https://t.co/KXbZxLizD0 
  7. Despite the FDA requiring TB testing for IL-17 inhibitors; no reported TB cases in 1st Yr RCTs and in vitro studies show no mTB reactivation with IL17inhibition  https://t.co/7A7fRUyaLN
  8. 167 RA patients that were serially assessed over 2 yrs; only BMD loss by DXA predicted Xray damage @ 12 & 24 mos; NOT DAS, RF, CCP, or ESR https://t.co/u6D6nJdKvx
  9. Study of 153K RA patients, 23% had Anemia,and review of their drugs found that anemia was only improved by tocilizumab, not with Tofa, DMARDs, other biologics. https://t.co/UY0DgU2usb
  10. New Recommendations on Biosimilar Use   
  11. Rheumatoid Arthritis Augments Cardiovascular Risk   
  12. Increasing Deaths and Breaking Bad with Fentanyl   
  13. Do Rheumatologists Use ACR/EULAR Guidance on Rheumatoid Arthritis? “Live Vote” Results   
  14. Hugo E. Jasin, MD (1933-2017)   
Disclosures: 
The author has received compensation as an advisor or consultant on this subject

Add new comment

More Like This

The RheumNow Week in Review - 19 January 2018

The RheumNow Week in Review discusses the past week's news, journal articles and highlights from RheumNow.com. This week's report covers the rising cost of adalimumab, infections in myositis, phyisician burnout, biologics in Still's disease and weight loss benefits in RA. 

Rheumatology Physician Burnout and Depression

The 2018 Medscape Physician Burnout and Depression report shows that 42% of physician respondents report "burnout" and up to 15% experience some sort of depression. In a survey of 15,543 doctors from 29 specialties, they found highest burnout rates in critical care and neurologists (48%), family medicine (47%), ob/gyns and internists (46%). Lowest rates were seen in pathology and dermatology (32%), and plastic surgery (23%). 

What did rheumatologists report?

The RheumNow Week in Review - 12 January 2018

Dr. Jack Cush reviews a dozen highlights from the past week on RheumNow.com.

40% of Arthritis Patients Fail to Receive Exercise Guidance

The latest issue of CDC’s MMWR reports that exercise counseling among arthritis patients increased from 52% to 61% (2002 to 2014); hence ~40% do not receive health care provider counseling, suggesting the need for provider education and training in exercise counseling, and improved electronic medical record reminders.

The RheumNow Week in Review - 5 January 2018

Dr Jack Cush reviews the news and journal articles from the past week on RheumNow.com.